pre-ipo
Stage
About
Epizyme is a biopharmaceutical company focused on the discovery and development of novel epigenetic therapies for cancer.
Explore Epizyme's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.